Mark William Lowdell, Chief Scientific Officer, 10% Owner at Inmune Bio, Inc. (INMB), sold 701 shares at $20.00 ($14K) on 2021-11-03, disclosed to the SEC on 2021-11-04.
Scheduled sale ($14k) by Chief Scientific Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INMB | SELL | 2021-10-26 | $8K | — | Filing → |
| INMB | SELL | 2021-07-09 | $1.1M | — | Filing → |
| INMB | BUY | 2019-09-12 | $18K | — | Filing → |